These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 17933458)

  • 1. A possible anti-proliferative and anti-metastatic effect of irradiated riboflavin in solid tumours.
    de Souza Queiroz KC; Zambuzzi WF; Santos de Souza AC; da Silva RA; Machado D; Justo GZ; Carvalho HF; Peppelenbosch MP; Ferreira CV
    Cancer Lett; 2007 Dec; 258(1):126-34. PubMed ID: 17933458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferruginol suppresses survival signaling pathways in androgen-independent human prostate cancer cells.
    Bispo de Jesus M; Zambuzzi WF; Ruela de Sousa RR; Areche C; Santos de Souza AC; Aoyama H; Schmeda-Hirschmann G; Rodríguez JA; Monteiro de Souza Brito AR; Peppelenbosch MP; den Hertog J; de Paula E; Ferreira CV
    Biochimie; 2008 Jun; 90(6):843-54. PubMed ID: 18294971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined effects of terazosin and genistein on a metastatic, hormone-independent human prostate cancer cell line.
    Chang KL; Cheng HL; Huang LW; Hsieh BS; Hu YC; Chih TT; Shyu HW; Su SJ
    Cancer Lett; 2009 Apr; 276(1):14-20. PubMed ID: 19091461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Keratocyte cytotoxicity of riboflavin/UVA-treatment in vitro.
    Wollensak G; Spoerl E; Reber F; Seiler T
    Eye (Lond); 2004 Jul; 18(7):718-22. PubMed ID: 14739922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3.
    Hellsten R; Johansson M; Dahlman A; Dizeyi N; Sterner O; Bjartell A
    Prostate; 2008 Feb; 68(3):269-80. PubMed ID: 18163422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential involvement of reactive oxygen species and nucleoside transporters in cytotoxicity induced by two adenosine analogues in human prostate cancer cells.
    Minelli A; Bellezza I; Tucci A; Rambotti MG; Conte C; Culig Z
    Prostate; 2009 Apr; 69(5):538-47. PubMed ID: 19107848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells.
    Yemelyanov A; Czwornog J; Gera L; Joshi S; Chatterton RT; Budunova I
    Cancer Res; 2008 Jun; 68(12):4763-73. PubMed ID: 18559523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts.
    Chiu FL; Lin JK
    Prostate; 2008 Jan; 68(1):61-71. PubMed ID: 18008333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasoactive intestinal peptide behaves as a pro-metastatic factor in human prostate cancer cells.
    Fernández-Martínez AB; Bajo AM; Sánchez-Chapado M; Prieto JC; Carmena MJ
    Prostate; 2009 May; 69(7):774-86. PubMed ID: 19189304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WRC-213, an l-methionine-conjugated mitoxantrone derivative, displays anticancer activity with reduced cardiotoxicity and drug resistance: identification of topoisomerase II inhibition and apoptotic machinery in prostate cancers.
    Hsiao CJ; Li TK; Chan YL; Hsin LW; Liao CH; Lee CH; Lyu PC; Guh JH
    Biochem Pharmacol; 2008 Feb; 75(4):847-56. PubMed ID: 18035333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
    Izumi K; Mizokami A; Li YQ; Narimoto K; Sugimoto K; Kadono Y; Kitagawa Y; Konaka H; Koh E; Keller ET; Namiki M
    Prostate; 2009 Aug; 69(11):1222-34. PubMed ID: 19434660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of cholesterol and phytosterols on cell proliferation, apoptosis and expression of a prostate specific gene in prostate cancer cell lines.
    Ifere GO; Barr E; Equan A; Gordon K; Singh UP; Chaudhary J; Igietseme JU; Ananaba GA
    Cancer Detect Prev; 2009; 32(4):319-28. PubMed ID: 19186008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo anticancer effects of the novel vitamin E ether analogue RRR-alpha-tocopheryloxybutyl sulfonic acid in prostate cancer.
    Ni J; Mai T; Pang ST; Haque I; Huang K; DiMaggio MA; Xie S; James NS; Kasi D; Chemler SR; Yeh S
    Clin Cancer Res; 2009 Feb; 15(3):898-906. PubMed ID: 19188160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nkx3.1 and p27(KIP1) cooperate in proliferation inhibition and apoptosis induction in human androgen-independent prostate cancer cells.
    Wang P; Ma Q; Luo J; Liu B; Tan F; Zhang Z; Chen Z
    Cancer Invest; 2009 May; 27(4):369-75. PubMed ID: 19266349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological values of medicinal mushrooms for prostate cancer therapy: the case of Ganoderma lucidum.
    Mahajna J; Dotan N; Zaidman BZ; Petrova RD; Wasser SP
    Nutr Cancer; 2009; 61(1):16-26. PubMed ID: 19116872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis of DU145 human prostate cancer cells induced by dehydrocostus lactone isolated from the root of Saussurea lappa.
    Kim EJ; Lim SS; Park SY; Shin HK; Kim JS; Park JH
    Food Chem Toxicol; 2008 Dec; 46(12):3651-8. PubMed ID: 18848968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (-)-Gossypol reduces invasiveness in metastatic prostate cancer cells.
    Huang YW; Wang LS; Dowd MK; Wan PJ; Lin YC
    Anticancer Res; 2009 Jun; 29(6):2179-88. PubMed ID: 19528479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of cell cycle events and apoptosis in mediating the anti-cancer activity of a silver(I) complex of 4-hydroxy-3-nitro-coumarin-bis(phenanthroline) in human malignant cancer cells.
    Thati B; Noble A; Creaven BS; Walsh M; McCann M; Devereux M; Kavanagh K; Egan DA
    Eur J Pharmacol; 2009 Jan; 602(2-3):203-14. PubMed ID: 19041861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermittent hormone therapy and its place in the contemporary endocrine treatment of prostate cancer.
    Shaw G; Oliver RT
    Surg Oncol; 2009 Sep; 18(3):275-82. PubMed ID: 19269165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of apoptosis by thiosulfinates in primary human prostate cancer cells.
    Kim SY; Park KW; Kim JY; Shon MY; Yee ST; Kim KH; Rhim JS; Yamada K; Seo KI
    Int J Oncol; 2008 Apr; 32(4):869-75. PubMed ID: 18360714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.